Geode Capital Management, LLC Hcw Biologics Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 183,259 shares of HCWB stock, worth $174,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares

183,259

Previous 170,385 7.56%

Holding current value

$174,096

Previous $110,000 10.91%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.42 - $0.7 $5,407 - $9,011	12,874 Added 7.56%	183,259 $98,000
Q2 2024 Aug 09, 2024	SELL	$0.64 - $1.68 $2,495 - $6,550	-3,899 Reduced 2.24%	170,385 $110,000
Q1 2024 May 13, 2024	BUY	$1.1 - $1.77 $43,832 - $70,530	39,848 Added 29.64%	174,284 $304,000
Q4 2023 Feb 13, 2024	BUY	$0.92 - $2.14 $1,778 - $4,136	1,933 Added 1.46%	134,436 $165,000
Q3 2023 Nov 13, 2023	BUY	$1.75 - $2.31 $2,570 - $3,393	1,469 Added 1.12%	132,503 $251,000
Q4 2022 Feb 13, 2023	SELL	$1.84 - $2.36 $515 - $660	-280 Reduced 0.21%	131,034 $251,000
Q3 2022 Nov 14, 2022	BUY	$2.13 - $2.74 $161,643 - $207,935	75,889 Added 136.92%	131,314 $300,000
Q2 2022 Aug 12, 2022	BUY	$1.96 - $3.17 $4,421 - $7,151	2,256 Added 4.24%	55,425 $121,000
Q1 2022 May 13, 2022	BUY	$1.9 - $2.73 $20,316 - $29,191	10,693 Added 25.17%	53,169 $145,000
Q4 2021 Feb 11, 2022	BUY	$2.32 - $4.73 $48,984 - $99,869	21,114 Added 98.84%	42,476 $98,000
Q3 2021 Nov 12, 2021	BUY	$3.14 - $6.3 $67,076 - $134,580	21,362 New	21,362 $68,000

Others Institutions Holding HCWB

# of Institutions

Shares Held

1.16M

Call Options Held

Put Options Held

View Full List

About HCW Biologics Inc.

Ticker HCWB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,833,100
Market Cap $34M
Description
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...

More about HCWB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Hcw Biologics Inc. Transaction History